《2021年套医学免疫学试题及答案.pdf》由会员分享，可在线阅读，更多相关《2021年套医学免疫学试题及答案.pdf（21页珍藏版）》请在taowenge.com淘文阁网|工程机械CAD图纸|机械工程制图|CAD装配图下载|SolidWorks_CaTia_CAD_UG_PROE_设计图分享下载上搜索。
1、模拟题（一）单选题填空题名词解释简答题问答题医学免疫学考试题A 一、单选题（只许从每题备选答案种选择一个最佳答案。每题1分，共 40分）1、外周免疫器官不包括（）A、胸腺 B、淋巴结 C、脾脏 D、粘膜相关淋巴组织2、人 B细胞分化成熟的部位是在（）A、胸腺 B、脾脏C、骨髓 D、法氏囊3、木瓜蛋白酶水解IgG所获片段中，能与抗原特异结合的是（）A、Fab段 B、Fc段 C、F（ab）2 段 D、pFc段4、参与新生儿溶血症的Ig 是（）A、IgG B、IgA C、IgM D、IgD 5、能抵抗蛋白酶水解的Ig 是（）A、IgG B、sIgA C、IgM D、IgE 6、以下关于 IgG 生物
2、学特性的错误叙述是（）A、能通过胎盘 B、能激活补体C、是参与 I 型超敏反应的主要 Ig D、能发挥调理作用7、参与旁路激活途径的补体成份是（）A、C1 B、C2 C、C3 D、C4 8、补体经典激活途径中形成的C3转化酶是（）A、C4b2b B、C3bBb C、C4b2b3b D、C3bnBb 9、下列补体裂解片段中具有调理作用的是（）A、C3a B、C3b C、C5a D、C5b 10、同时参与经典、旁路及MBL 三条激活途径的补体成分是（）精品w o r d 学习资料 可编辑资料-精心整理-欢迎下载-第 1 页，共 21 页A、C1 B、C2 C、C3 D、C4 11、细胞因子（CK）
3、的生物学作用特点不包括（）A、具有高效性 B、为特异性作用C、多数在局部发挥作用 D、对细胞的作用不受MHC限制12、能直接杀伤肿瘤细胞的细胞因子是（）A、TNF B、IFN C、IL-1 D、IL-2 13、干扰素（IFN）不具有（）A、抗病毒作用 B、抗肿瘤作用C、免疫调节作用 D、炎症介质作用14、以下关于 CD8 分子的叙述，正确的是（）A、是辅助 T细胞（Th）的膜分子 B、是细胞毒 T细胞（Tc）的膜分子C、是Th细胞识别抗原的辅助受体 D、是 HIV 的受体15、经典的 HLA I 类基因是（）A、HLA-DP B、HLA-DQ C、HLA-C D、HLA-DR 16、HLA 复
4、合体位于人的哪号染色体上（）A、1号染色体 B、2 号染色体C、6号染色体D、17号染色体17、HLA 类抗原主要分布于（）A、各种有核细胞，包括血小板和网织红细胞B、各种白细胞和红细胞C、淋巴细胞、粒细胞、红细胞及抗原提呈细胞（APC）D、B细胞、单核/巨噬细胞（M）、树突状细胞（DC）及活化T细胞18、T细胞的抗原识别受体是（）A、TCR B、CD3 分子 C、补体受体 D、细胞因子受体19、B胞胞不具有的表面标志是（）A、CD3 分子 B、BCR C、Fc受体 D、补体受体（CR）20、能特异杀伤靶细胞并有MHC 限制性的是（）精品w o r d 学习资料 可编辑资料-精心整理-欢迎下载
5、-第 2 页，共 21 页文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO
6、3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D
7、8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO
8、3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D
9、8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO
10、3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D
11、8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6A、M B、Tc 细胞 C、NK 细胞 D、B 细胞21、专职性 APC 不包括（）A、DC B、M C、B细胞 D、NK细胞22、不同物种间共有的抗原称为（）A、TD 抗原 B、TI 抗原C、异嗜性抗原 D、异种抗原23、胸腺依赖性抗原(TD-Ag)是指()A、来源于胸腺的抗原 B、刺激 B细胞产生抗体需 T细胞辅助的抗原C、在胸
12、腺中加工处理的抗原 D、T细胞在胸腺内发育过程中获得的抗原24 胸腺非依赖抗原(TI-Ag)诱导B细胞产生抗体的特点是（）A、需Th细胞辅助 B、能诱导记忆 B细胞形成C、一般仅产生 IgM类抗体 D、主要产生 IgG类抗体25、机体在哪个时期对抗原刺激最易产生免疫耐受()A、成年期 B、老年期 C、新生期 D、胚胎期26、固有免疫（或非特异性免疫）的特点不包括()A、多经遗传获得 B、作用发挥快C、作用无严格针对性D、有免疫记忆性27、皮肤和粘膜上皮细胞及其附属成分的防御功能体现在()A、物理屏障作用 B、化学屏障作用C、微生物屏障作用D、以上均是28、参与固有免疫的效应分子不包括()A、补
13、体 B、溶菌酶 C、抗毒素 D、防御素29、NK 细胞的 ADCC 是下列哪类 Ig 介导的()A、IgA B、IgG C、IgM D、IgE 30、M 的生物学功能不包括()A、吞噬杀伤病原体的作用 B、提呈抗原作用C、抗肿瘤作用 D、特异性识别抗原作用31、下列哪种细胞不参与I 型超敏反应（）A、Tc细胞 B、肥大细胞 C、嗜碱性粒细胞 D、B细胞精品w o r d 学习资料 可编辑资料-精心整理-欢迎下载-第 3 页，共 21 页文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6
14、文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3
15、R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6
16、文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3
17、R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6
18、文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3
19、R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6
20、文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U632、脱敏治疗适合于（）A、青霉素皮试阳性者 B、抗毒素皮试阳性的病人C、结核菌素皮试阳性者 D、以上均可33、属于 II 型超敏反应的疾病是（）A、支气管哮喘 B、血清病C、甲状腺机能亢进D、过敏性休克34、下列哪种疾病的发病机制主要属于型超敏反应A、类风湿关节炎 B、过敏性皮炎C、自身免疫性溶血性贫血 D、新生儿溶血症35、下列关于肿瘤免疫的叙述错误的是A细胞免疫是抗肿瘤免疫的主要机制B抗体在抗肿瘤中并不发挥主要作用CNK 细胞是抗肿瘤的第一道防线D静止和活化的巨噬细胞均能杀瘤细胞36、性联无丙种球蛋白血症的发
21、病机制是（）A、BtK 缺陷B、CD40L 缺陷C、ZAP-70 缺陷D、ADA 缺陷37、胰岛素依赖型糖尿病的发生机制是A型超敏反应B型超敏反应C型超敏反应D型超敏反应38、HLA 不相匹配的骨髓移植用于治疗免疫缺陷病 时，易发生（）A、移植物抗宿主反应（GVHR）B、宿主抗移植物反应C、自身免疫病D、肿瘤39、以下免疫学检测技术中，最为灵敏的方法是（）A、放射免疫测定B、免疫荧光技术C、免疫酶标技术D、间接凝集反应40、用于人工自动免疫的生物制剂是（）A、抗毒素B、丙种球蛋白C、类毒素D、抗Rh球蛋白二、填空题（每空 0。5分，共 10分）41、人类中枢免疫器官包括（）和（）。42、在五类
22、 Ig 中，分子量最大的是（）；参与粘膜免疫的主要是（sIgA ）。精品w o r d 学习资料 可编辑资料-精心整理-欢迎下载-第 4 页，共 21 页文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T
23、3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编
24、码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T
25、3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编
26、码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T
27、3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编
28、码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U643、补体经典途径的激活物主要是（），该途径形成的C5转化酶是（）。44、效应性 T细胞主要包括（）和（）两个亚群。45、B细胞的抗原识别受体是（），其识别的抗原无需（）细胞进行加工处理。46、完全抗原具有
29、（）和（）两种特性。47、参与 II 型和 III型超敏反应的 Ig 主要是（）和（）。48、输血反应属于（II ）型超敏反应；血清病属于（）型超敏反应。49、肿瘤抗原按特异性可分为（）和（）两类。50、通过人工免疫使机体获得特异性免疫力的方法主要有（）和（）两类。三、名词解释（每题词3分，共 15分）51、抗体52、免疫耐受53、MHC 54、抗原决定簇55、细胞因子四、简答题（每题5分，共 25分）56、补体系统可通过哪些方式引起炎症反应？57、胸腺依赖抗原（D-Ag）引起的免疫应答有何特点？58、试述免疫缺陷病的共同临床特点。59、比较人工主动免疫与人工被动免疫的主要区别。60、简述 I
30、 型超敏反应的特点。五、问答题（10分）61、试述母胎 Rh血型不合所致的新生儿浴血症的发生机制及其预防方法。参考答案一、单选题1、A 2、C 3、A 4、A 5、B 6、C 7、C 8、A 9、B 10、C 11、B 12、A 13、D 14、B 15、C 16、C 17、D 18、A 19、A 20、B 精品w o r d 学习资料 可编辑资料-精心整理-欢迎下载-第 5 页，共 21 页文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8
31、T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档
32、编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8
33、T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档
34、编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8
35、T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档
36、编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8
37、T3M6D8 ZX5Q5G3G9U621、D 22、C 23、B 24、C 25、D 26、D 27、D 28、C 29、B 30、D 31、A 32、B 33、C 34、A 35、D 36、A 37、C 38、A 39、A 40、C 二、填空题41、骨髓胸腺42、IgM sIgA 43、抗原抗体复合物/免疫复合物 C4b2b3b 44、CTL/Tc细胞 Th1细胞45、BCR APC 46、免疫原性免疫反应性/抗原性47、IgG IgM 48、II 49、肿瘤特异性抗原/TSA 肿瘤相关抗原/TAA 50、人工主动免疫人工被动免疫三、名词51、抗体：是 B细胞受抗原刺激后，分为浆细胞所合成分
38、泌的一类能与相应抗原特异性结合的具有免疫功能的球蛋白。52、免疫耐受：指机体免疫系统接受某种抗原刺激后产生的特异性免疫无应答状态。53、MHC：即主要组织相容性复合体，是位于脊椎动物某一染色体上一组紧密连锁的基因群，其产物能提呈抗原，启动和调控特异性免疫应答。54、抗原决定簇：指存在于抗原分子表面的能决定特异性的特殊化学基团，又称为表位。55、细胞因子：指由活化免疫细胞或非免疫细胞合成分泌的能调节细胞生理功能、介导炎症反应、参与免疫应答和组织修复等多种生物学效应的小分子多肽。四、简答题56、补体系统可通过以下方式介导炎症反应（1）激肽样作用：C2a能增加血管通透性，引起炎症性充血；（2）过敏毒
39、素作用：C3a、C4a、C5a 可使肥大细胞、嗜碱性粒细胞脱颗粒，释放组胺等介质，引起炎症性充血、水肿；（3）趋化作用：C3a、C5a 能吸引中性粒细胞和单核巨噬细胞等向炎症部位聚集，引起炎性细胞侵润。精品w o r d 学习资料 可编辑资料-精心整理-欢迎下载-第 6 页，共 21 页文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3
40、G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8
41、 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3
42、G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8
43、 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3
44、G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8
45、 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6 57、TD-Ag引起的免疫应答特点是（1）既能引起体液免疫应答，也能引
46、起细胞免疫应答；（2）产生的抗体以 IgG为主，也可产生其他类别抗体；（3）可产生免疫记忆，能引起再次应答。58、免疫缺陷病的共同临床特点是（1）易发生感染，是因免疫缺陷导致机体防御功能低下所致.感染微生物种类与缺陷类型有关,体液免疫缺陷、吞噬细胞缺陷和补体缺陷者，易发生化脓性细菌感染；细胞免疫缺陷者，易发生病毒、真菌、胞内寄生菌和原虫的感染；（2）肿瘤发生率增高，比正常同龄人高100300倍，以白血病和淋巴系统肿瘤常见；（3）自身免疫病发病率明显增高，以SLE、RA 和恶性贫血常见。；59、人工主动免疫人工被动免疫接种物质抗原（疫苗、类毒素）抗体（活化的淋巴细胞、细胞因子等）接种次数 1-3
47、次 1次潜伏期较长，约 1-4周较短，立即生效维持时间较长、数月至数年较短，2-3周主要用途预防传染病、治疗肿瘤等疾病的治疗或紧急预防 60、I 型超敏反应的特点是：（1）反应发生快，消退也快；（2）由IgE抗体介导；（3）组胺等生物介质参与反应；（4）主要引起生理功能紊乱，无明显组织损伤；（5）有明显的个体差异和遗传倾向。五、问答题61、（1）新生儿溶血的反应机制是：发生于Rh-孕妇所怀的 Rh+胎儿。当第一胎分娩时，若胎盘剥离出血，胎儿Rh+细胞进入母体，可刺激母体产生 Rh抗体（为 IgG）。当母体怀第二胎，胎儿又是Rh+精品w o r d 学习资料 可编辑资料-精心整理-欢迎下载-第
48、7 页，共 21 页文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3
49、K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 Z
50、X5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3K2U1L8 HN3R8T3M6D8 ZX5Q5G3G9U6文档编码:CO3K3